Eden Research PLC (LON:EDEN) has been granted two important patents for its technology in the USA.
The AIM-quoted company focused on sustainable biopesticides said it has secured patents for its Sustaine encapsulation technology and compositions for insecticide products from the US Patent Office.
Sustaine microcapsules are naturally sourced, plastic-free, biodegradable micro-spheres derived from yeast extract. The Sustaine microencapsulation technology enables the use of naturally occurring terpenes for application in commercial crop protection, Eden said.
The initial patent provides broad compositional protection for the encapsulation of terpenes in hollow cell wall particles. The second patent provides protection for the use of compositions in a method of killing mites or treating/preventing a mite infestation, which is a designed use for Eden's new insecticide products.
READ Eden Research raises £10.1mln to commercialise insecticide products
The insecticide products will add to the company's current suite of products. Eden's biopesticide product portfolio is based upon the combination of plant-derived active ingredients and the Sustaine microencapsulation system.
Eden said its plant protection products offer ease of use and efficacy on a par with conventional pesticides while being exempt from maximum residue levels in Europe and having low or no pre-harvest intervals, giving growers maximum control and flexibility.
Shares in Eden Research were up 4.9% at 8.05p in early deals.